Entrada Therapeutics, Inc. — All Filings
427 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
10-Q/A
144
3
3/A
4
4/A
424B4
424B5
8-A12B
8-K
ARS
CERT
CORRESP
D
D/A
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
PRE 14A
S-1
S-1/A
S-1MEF
S-3
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 4 | FORM 4 | 0001873392-26-000002 | Mar 11, 2026 | Mar 9, 2026 |
| 4 | FORM 4 | 0001725663-26-000003 | Mar 11, 2026 | Mar 9, 2026 |
| 144 | — | 0001950047-26-002377 | Mar 9, 2026 | — |
| 144 | — | 0001950047-26-002366 | Mar 9, 2026 | — |
| 4 | FORM 4 | 0001725663-26-000002 | Mar 6, 2026 | Mar 4, 2026 |
| 144 | — | 0001950047-26-002210 | Mar 4, 2026 | — |
| 4 | FORM 4 | 0001613084-26-000001 | Mar 3, 2026 | Mar 1, 2026 |
| 4 | FORM 4 | 0001725663-26-000001 | Mar 3, 2026 | Mar 1, 2026 |
| 4 | FORM 4 | 0001873392-26-000001 | Mar 3, 2026 | Mar 1, 2026 |
| 4 | FORM 4 | 0001873394-26-000001 | Mar 3, 2026 | Mar 1, 2026 |
| S-8 | FORM S-8 | 0001104659-26-020086 | Feb 26, 2026 | — |
| 10-K | 10-K | 0001689375-26-000011 | Feb 26, 2026 | Dec 31, 2025 |
| 8-K | 8-K | 0001689375-26-000009 | Feb 26, 2026 | — |
| 8-K | 8-K | 0001689375-26-000003 | Jan 8, 2026 | — |
| EFFECT | — | 9999999995-25-003504 | Dec 3, 2025 | — |
| SCHEDULE 13G | — | 0001193125-25-297315 | Nov 25, 2025 | — |
| 4 | FORM 4 | 0001725663-25-000004 | Nov 24, 2025 | Nov 21, 2025 |
| 4 | 4 | 0001193125-25-293698 | Nov 24, 2025 | Nov 20, 2025 |
| 144 | — | 0001950047-25-009207 | Nov 21, 2025 | — |
| SCHEDULE 13D/A | — | 0001674324-25-000005 | Nov 18, 2025 | — |
| 4 | — | 0001664281-25-000003 | Nov 18, 2025 | Nov 14, 2025 |
| 4 | — | 0001231919-25-000522 | Nov 18, 2025 | Nov 14, 2025 |
| 144 | — | 0001674324-25-000003 | Nov 14, 2025 | — |
| SCHEDULE 13G/A | — | 0000080255-25-000842 | Nov 14, 2025 | — |
| 4 | 4 | 0001193125-25-278038 | Nov 12, 2025 | Nov 10, 2025 |
| S-3 | FORM S-3 | 0001104659-25-107397 | Nov 6, 2025 | — |
| 10-Q | 10-Q | 0001689375-25-000050 | Nov 6, 2025 | Sep 30, 2025 |
| 8-K | 8-K | 0001689375-25-000049 | Nov 6, 2025 | — |
| 4 | FORM 4 | 0001613084-25-000003 | Sep 4, 2025 | Sep 2, 2025 |
| 4 | FORM 4 | 0001873392-25-000003 | Sep 4, 2025 | Sep 2, 2025 |
| 4 | FORM 4 | 0001873394-25-000003 | Sep 4, 2025 | Sep 2, 2025 |
| 4 | FORM 4 | 0001725663-25-000003 | Sep 4, 2025 | Sep 2, 2025 |
| SCHEDULE 13G/A | — | 0000080255-25-000607 | Aug 14, 2025 | — |
| 10-Q | 10-Q | 0001689375-25-000043 | Aug 6, 2025 | Jun 30, 2025 |
| 8-K | 8-K | 0001689375-25-000041 | Aug 6, 2025 | — |
| 4 | — | 0001415889-25-019680 | Jul 11, 2025 | Jul 9, 2025 |
| 4 | — | 0001415889-25-019677 | Jul 11, 2025 | Jul 9, 2025 |
| 144 | — | 0000803012-25-000019 | Jul 9, 2025 | — |
| 144 | — | 0000803012-25-000018 | Jul 9, 2025 | — |
| 4 | — | 0001415889-25-018824 | Jul 1, 2025 | Jun 27, 2025 |
| 4 | — | 0001415889-25-018822 | Jul 1, 2025 | Jun 27, 2025 |
| 144 | — | 0000803012-25-000017 | Jul 1, 2025 | — |
| 144 | — | 0000803012-25-000016 | Jul 1, 2025 | — |
| 144 | — | 0000803012-25-000015 | Jun 30, 2025 | — |
| 144 | — | 0000803012-25-000014 | Jun 30, 2025 | — |
| 144 | — | 0000803012-25-000013 | Jun 27, 2025 | — |
| 144 | — | 0000803012-25-000012 | Jun 27, 2025 | — |
| 4/A | FORM 4/A | 0001689375-25-000035 | Jun 18, 2025 | May 13, 2024 |
| 4 | FORM 4 | 0001689375-25-000034 | Jun 12, 2025 | Jun 11, 2025 |
| 4 | FORM 4 | 0001689375-25-000033 | Jun 12, 2025 | Jun 11, 2025 |